Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance imaging contrast enhancement refers to the use of specialized agents—most commonly gadolinium-based contrast agents (GBCAs)—to improve the visibility and differentiation of internal body structures during MRI scans. These agents are administered intravenously or orally, depending on the area being imaged, and work by altering the magnetic properties of nearby water protons, thereby enhancing image contrast.
Shortening T1/T2 relaxation times via paramagnetic interactions between agent metal ions (primarily gadolinium) and tissue water protons
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Imaging Contrast Enhancement.